Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 197
interventional 166
Observational 29
Registry 2

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 66
Drug|placebo 48
Dietary Supplement|placebo 12
Behavioral 11
Dietary Supplement 9
Biological|Drug|placebo 3
Behavioral|Drug 2
Biological|placebo 2
Device 2
Procedure 2
Behavioral|Device 1
Behavioral|Dietary Supplement|Drug|placebo 1
Behavioral|Dietary Supplement|placebo 1
Behavioral|Other 1
Biological|Drug 1
Combination Product|Drug|placebo 1
Drug|Other 1
Other 1
Other|placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 46
NA 27
Korea, Republic of 20
Canada 8
China 6
Netherlands 6
United States|Canada 4
Australia 3
Taiwan 3
France 2
Germany 2
India 2
Iran, Islamic Republic of 2
Japan 2
Mexico 2
Spain 2
United States|Brazil|Canada|Singapore|South Africa|Taiwan|United Kingdom 2
Belgium|Colombia|Finland|Germany|Israel|Italy|Mexico|Netherlands|Norway|Peru|South Africa|Spain|Sweden 1
Belgium|France|Germany 1
Bulgaria|Czech Republic|Germany|Slovakia|Ukraine 1
Czech Republic|Denmark|France|Germany|Hungary|Netherlands|Poland|Ukraine 1
Denmark 1
Germany|Netherlands 1
Greece|Israel|Romania|Russian Federation|South Africa 1
Italy|Poland|Portugal|United States|Australia|Belgium|Brazil|Canada|France|Greece|Romania|South Africa|Spain|Switzerland|United Kingdom 1
Lebanon 1
Malaysia 1
Norway 1
Norway|South Africa 1
Poland 1
Turkey 1
Ukraine|Poland|Italy 1
United Kingdom 1
United States|Argentina|Brazil|Canada|China|Colombia|France|Korea, Republic of|Russian Federation|Turkey 1
United States|Australia|Austria|Belgium|Canada|Czechia|Denmark|France|Germany|Hong Kong|Hungary|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Norway|Poland|Russian Federation|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Canada|Czech Republic|Germany|Hong Kong|Italy|Korea, Republic of|Poland 1
United States|Brazil|Bulgaria|Canada|Denmark|Germany|Hungary|Italy|Mexico|Romania|South Africa 1
United States|Brazil|Canada|France|Germany|Israel|Italy|Netherlands|South Africa|Spain|United Kingdom 1
United States|Canada|Czechia|Finland|Korea, Republic of|Netherlands|Norway|Poland|Puerto Rico|Singapore|Sweden|United Kingdom 1
United States|Canada|Denmark|Germany|Netherlands 1
United States|Canada|Germany|Netherlands|Poland|United Kingdom 1
United States|Canada|Netherlands 1
United States|China 1
United States|Hungary|Canada|Colombia|France|Lithuania|Mexico|Romania|Russian Federation|Spain|Taiwan|United Kingdom 1

Sites per Study

Site_count Study_Count
1 105
2 10
3 2
4 4
5 6
6 1
10 2
12 1
13 1
14 1
15 2
17 1
18 1
19 1
26 1
28 1
30 1
32 1
33 2
36 1
40 1
41 1
43 1
44 2
46 1
54 1
57 1
67 1
68 1
75 1
78 2
103 1
104 1
107 1
110 2
223 1
249 1
363 1

Phase

Phase Study_Count
Phase 3 61
N/A 32
Phase 2 28
Phase 4 28
Phase 1 6
Phase 2/Phase 3 6
Phase 1/Phase 2 4
Early Phase 1 1

Number of Arms

Number_of_Arms Count_of_Studies
1 8
2 64
3 30
4 20
5 2
6 5
8 1
9 1
NA 35

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 74 16.0 7.00000 8.0 2.0000 30.00 18.0000 11.0000
1st Qu. 74 41.5 12.50000 36.5 34.0000 56.25 156.0000 53.5000
Median 74 71.0 35.00000 49.0 120.0000 70.00 299.0000 93.0000
Mean 74 306.5 57.83333 53.5 143.2593 90.50 551.5082 434.1071
3rd Qu. 74 170.0 57.50000 66.0 205.5000 108.50 646.0000 245.5000
Max. 74 4078.0 200.00000 108.0 619.0000 200.00 3681.0000 8000.0000

Trial Group Type

group_type Group_Count
Experimental 176
Active Comparator 95
Placebo Comparator 75
NA 35
No Intervention 11
Other 5
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 127
Single Group Assignment 16
Crossover Assignment 15
NA 5
Factorial Assignment 3

Primary Purpose

primary_purpose Study_Count
Treatment 131
Prevention 21
Basic Science 3
Health Services Research 3
Supportive Care 3
Diagnostic 1
Educational/Counseling/Training 1
Other 1
Screening 1
NA 1

Observational Studies

Studies by Country

Country Study_Count
NA 8
United States 5
Austria 3
Germany 2
Taiwan 2
Austria|Belgium|France|Germany|Greece|Norway|Russian Federation|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Belgium|Austria|Bulgaria|Czechia|Germany|Greece|Italy|Portugal|Slovakia|Spain|Sweden|Switzerland 1
China 1
Denmark 1
Greece 1
Korea, Republic of 1
Mexico 1
Sweden 1
Thailand 1

Sites per Study

Site_count Study_Count
1 21
7 1
8 1
11 1
12 1
15 1
17 1
190 1
778 1

Enrollment Metrics

Measure Observational
Min 31.000
1st Qu 137.000
Median 600.000
Mean 1330.037
3rd Qu 1744.000
Max 7200.000

Observation Model

observational_model Study_Count
Cohort 13
NA 6
Other 3
Case Control 2
Family-Based 2
Case-Only 1
Case Control, Natural History 1
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 17
Cross-Sectional 5
NA 5
Cross-Sectional, Prospective 1
Retrospective 1

Registries

Studies by Country

Country Study_Count
Germany 1
Poland 1

Sites per Study

Site_count Study_Count
1 2

Enrollment Metrics

Measure Registries
Min 16
1st Qu 6262
Median 12508
Mean 12508
3rd Qu 18754
Max 25000

Registry Model

observational_model Study_Count
Cohort 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 2

Follow-up

target_duration Study_Count
15 Years 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03360747 Phase 2 Study of AKCEA-ANGPTL3-LRX (ISIS 703802) in Patients With Familial Chylomicronemia Syndrome (FCS) https://ClinicalTrials.gov/show/NCT03360747 Completed Akcea Therapeutics 2018-09-04
NCT03337308 A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy https://ClinicalTrials.gov/show/NCT03337308 Completed Esperion Therapeutics 2018-06-18
NCT03330548 Pilot Study on the Effects of a Plant-Strong Diet on Cardiovascular Risk Factors https://ClinicalTrials.gov/show/NCT03330548 Recruiting Phoenix VA Health Care System 2021-05-31
NCT03079648 Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Blood Triglyceride https://ClinicalTrials.gov/show/NCT03079648 Completed Chonbuk National University Hospital 2018-04-06
NCT03070782 Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Patients With Hyperlipoproteinemia(a) and Cardiovascular Disease https://ClinicalTrials.gov/show/NCT03070782 Completed Akcea Therapeutics 2018-07-18
NCT03067688 Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia https://ClinicalTrials.gov/show/NCT03067688 Completed Yuhan Corporation 2018-03-27
NCT02991534 Cardiovascular Risk Screening and Risk Reduction in Women Vets https://ClinicalTrials.gov/show/NCT02991534 Recruiting VA Office of Research and Development 2020-08-31
NCT02991118 Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk https://ClinicalTrials.gov/show/NCT02991118 Completed Esperion Therapeutics 2018-08-22
NCT02959762 Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K ‘n’ Kids Study II) https://ClinicalTrials.gov/show/NCT02959762 Active, not recruiting Augusta University 2020-12-01
NCT02942602 Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT02942602 Completed Yonsei University 2016-05-23
NCT02899455 Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia https://ClinicalTrials.gov/show/NCT02899455 Completed Hanmi Pharmaceutical Company Limited 2016-06-30
NCT02842359 Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension https://ClinicalTrials.gov/show/NCT02842359 Completed Sanofi 2018-04-19
NCT02824432 Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation https://ClinicalTrials.gov/show/NCT02824432 Completed Takeda 2017-08-19
NCT02767531 Orlistat for the Treatment of Type I Hyperlipoproteinemia https://ClinicalTrials.gov/show/NCT02767531 Active, not recruiting University of Texas Southwestern Medical Center 2018-05-31
NCT02742545 Impact of MayoExpertAdvisor on Provider Adherence https://ClinicalTrials.gov/show/NCT02742545 Completed Mayo Clinic 2016-11-30
NCT02729025 Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a)) https://ClinicalTrials.gov/show/NCT02729025 Completed Amgen 2018-04-05
NCT02719028 Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia https://ClinicalTrials.gov/show/NCT02719028 Completed Golden Biotechnology Corporation 2018-09-27
NCT02668016 Self-Assessment Method for Statin Side-effects Or Nocebo https://ClinicalTrials.gov/show/NCT02668016 Active, not recruiting Imperial College London 2020-02-29
NCT02666664 Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony) https://ClinicalTrials.gov/show/NCT02666664 Completed Esperion Therapeutics 2018-02-21
NCT02662569 Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT02662569 Completed Amgen 2017-12-06
NCT02658175 The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome https://ClinicalTrials.gov/show/NCT02658175 Active, not recruiting Ionis Pharmaceuticals, Inc. 2020-06-30
NCT02593032 Effects of Use of a Connected Pillbox On Medication Adherence https://ClinicalTrials.gov/show/NCT02593032 Completed University of Pennsylvania 2017-04-30
NCT02582424 Safety and Efficacy of PDL-0101 in Patients With Hyperlipidemias: a Pilot Study. https://ClinicalTrials.gov/show/NCT02582424 Completed Primus Pharmaceuticals 2013-08-31
NCT02512276 Tele-Pharmacy Intervention to Improve Treatment Adherence https://ClinicalTrials.gov/show/NCT02512276 Completed Brigham and Women’s Hospital 2017-08-31
NCT02458287 Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia https://ClinicalTrials.gov/show/NCT02458287 Completed Pfizer 2016-02-29
NCT02418637 Pilot Study Testing Feasibility of Health Screening at Farm Site https://ClinicalTrials.gov/show/NCT02418637 Completed Mayo Clinic 2016-09-30
NCT02295293 The Effects of Rhus Coriaria L. on Serum Lipid Levels of Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT02295293 Completed Shiraz University of Medical Sciences 2015-04-30
NCT02280590 Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT02280590 Completed Dong-A ST Co., Ltd. 2015-06-30
NCT02215408 MEDication Focused Outpatient Care for Underutilization of Secondary Prevention https://ClinicalTrials.gov/show/NCT02215408 Completed University of Iowa 2017-06-30
NCT02189837 Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody https://ClinicalTrials.gov/show/NCT02189837 Completed Amgen 2015-02-13
NCT02135029 Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins https://ClinicalTrials.gov/show/NCT02135029 Completed Pfizer 2015-11-30
NCT02130505 Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes https://ClinicalTrials.gov/show/NCT02130505 Completed Sint Franciscus Gasthuis 2008-06-30
NCT02100514 Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events https://ClinicalTrials.gov/show/NCT02100514 Completed Pfizer 2016-07-15
NCT02098278 Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia https://ClinicalTrials.gov/show/NCT02098278 Completed Catabasis Pharmaceuticals 2015-04-30
NCT01317524 The Effects of Homogenized and Unhomogenized Milk on Postprandial Metabolism in Healthy Overweight Men https://ClinicalTrials.gov/show/NCT01317524 Completed Maastricht University Medical Center 2011-06-30
NCT01308710 The Effects of a Mediterranean Diet in Pediatric Hyperlipidemia https://ClinicalTrials.gov/show/NCT01308710 Completed University of California, San Francisco 2011-07-31
NCT01291641 Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease https://ClinicalTrials.gov/show/NCT01291641 Completed Seoul National University Hospital 2016-12-31
NCT01279590 Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM) https://ClinicalTrials.gov/show/NCT01279590 Completed Furiex Pharmaceuticals, Inc 2011-11-30
NCT02056847 to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia https://ClinicalTrials.gov/show/NCT02056847 Completed JW Pharmaceutical 2017-05-31
NCT02029989 Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness https://ClinicalTrials.gov/show/NCT02029989 Completed University of Minnesota 2012-02-29
NCT02008084 A Pilot Study to Evaluate the Lipid Effects of TRIA-662 https://ClinicalTrials.gov/show/NCT02008084 Completed Cortria Corporation 2015-10-31
NCT01968967 Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events https://ClinicalTrials.gov/show/NCT01968967 Completed Pfizer 2016-07-05
NCT01968954 Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events https://ClinicalTrials.gov/show/NCT01968954 Completed Pfizer 2016-04-30
NCT01953328 Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk https://ClinicalTrials.gov/show/NCT01953328 Completed Amgen 2014-06-30
NCT01918332 Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia https://ClinicalTrials.gov/show/NCT01918332 Completed LG Life Sciences 2013-03-31
NCT01914432 Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia https://ClinicalTrials.gov/show/NCT01914432 Completed Yuhan Corporation 2014-06-30
NCT01912560 Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT01912560 Completed Catabasis Pharmaceuticals 2013-12-31
NCT01884246 Improving Heart Health in Appalachia https://ClinicalTrials.gov/show/NCT01884246 Completed University of Kentucky 2016-12-31
NCT01878227 Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT01878227 Completed Zhejiang University 2011-05-31
NCT01865370 Efficacy and Safety of Kochujang Pills on Blood Lipids Profiles in Hyperlipidemia Subjects https://ClinicalTrials.gov/show/NCT01865370 Completed Chonbuk National University Hospital 2012-02-29
NCT01854918 Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT01854918 Completed Amgen 2018-05-31
NCT01845428 Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome https://ClinicalTrials.gov/show/NCT01845428 Completed University of North Carolina, Chapel Hill 2017-01-31
NCT01811082 Comparison of Coenzyme A and Pantethine Capsule for Safety and Efficacy On Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT01811082 Completed Zhejiang University 2011-05-31
NCT01680211 Safety and Efficacy Study of Herbal Supplements in Prediabetic and Mild to Moderate Hyperlipidemic Patients https://ClinicalTrials.gov/show/NCT01680211 Completed Olive Lifesciences Pvt Ltd 2012-06-30
NCT01675154 Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia https://ClinicalTrials.gov/show/NCT01675154 Active, not recruiting University of Texas Southwestern Medical Center 2020-07-31
NCT01562080 Combined Effects of Bioactive Compounds in Lipid Profile https://ClinicalTrials.gov/show/NCT01562080 Completed Rottapharm Spain 2012-06-30
NCT01541943 Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia https://ClinicalTrials.gov/show/NCT01541943 Completed HanAll BioPharma Co., Ltd. 2014-11-30
NCT01524289 Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020) https://ClinicalTrials.gov/show/NCT01524289 Completed Merck Sharp & Dohme Corp. 2014-02-12
NCT01442987 Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia https://ClinicalTrials.gov/show/NCT01442987 Completed Hanmi Pharmaceutical Company Limited 2013-04-30
NCT01414803 Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia https://ClinicalTrials.gov/show/NCT01414803 Completed Yonsei University 2011-04-30
NCT01402102 A Human Trial to Evaluate the Efficacy and Safety of Aged Garlic Powder on Improvement of Blood Lipids in Subjects With Hyperlipidemia https://ClinicalTrials.gov/show/NCT01402102 Completed Chonbuk National University Hospital 2011-03-31
NCT01388816 A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels https://ClinicalTrials.gov/show/NCT01388816 Completed Dr. Reddy’s Laboratories Limited 2012-05-31
NCT01360567 The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia https://ClinicalTrials.gov/show/NCT01360567 Completed Taipei City Hospital 2012-11-30
NCT01349010 Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia https://ClinicalTrials.gov/show/NCT01349010 Completed Otsuka Beijing Research Institute 2012-07-31
NCT01332747 Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation https://ClinicalTrials.gov/show/NCT01332747 Completed Jamia Hamdard University 2011-05-31
NCT01327014 Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT01327014 Completed Beijing Peking University WBL Biotech Co., Ltd. 2012-12-31
NCT04209244 Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT04209244 Recruiting Rigshospitalet, Denmark 2023-07-31
NCT04069715 The Effect of Farlong® NotoGinsengâ„¢ (Farlong® Ginseng Plu®) on Cholesterol and Blood Pressure https://ClinicalTrials.gov/show/NCT04069715 Enrolling by invitation LongStar HealthPro, Inc. DBA Farlong Pharmaceutical 2020-02-28
NCT04036773 Food Pharmacy at Oregon Health & Science University (OHSU) Knight Cardiovascular Institute (KCVI) https://ClinicalTrials.gov/show/NCT04036773 Recruiting Oregon Health and Science University 2020-07-15
NCT03944109 The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With Hyperlipidemia https://ClinicalTrials.gov/show/NCT03944109 Recruiting Jiangsu HengRui Medicine Co., Ltd. 2020-06-30
NCT03857256 Compare the Efficacy and Safety of Beta-Glucan as Add-On to Statin in Subjects With Hyperlipidemia. https://ClinicalTrials.gov/show/NCT03857256 Recruiting Montreal Heart Institute 2020-11-01
NCT03680027 Effects Of Walnut-Enriched Diet On Blood Lipids And Glucose Profiles In Hyperlipidemic Subjects https://ClinicalTrials.gov/show/NCT03680027 Completed Eastern Mediterranean University 2015-08-27
NCT03639480 Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT03639480 Enrolling by invitation CJ HealthCare Corporation 2018-10-31
NCT03607383 Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study https://ClinicalTrials.gov/show/NCT03607383 Recruiting Saint-Joseph University 2020-04-30
NCT03566316 Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT03566316 Completed IlDong Pharmaceutical Co Ltd 2017-06-16
NCT03550287 Evaluation of the Effect of a Shiitake Extract on Lipid Profile in Subjects With Moderate Hyperlipidemia https://ClinicalTrials.gov/show/NCT03550287 Completed Instituto de Investigación Hospital Universitario La Paz 2017-06-30
NCT03536598 Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT03536598 Completed CJ HealthCare Corporation 2017-09-04
NCT03434613 A Randomized, Prospective, Open Label, Active Control, Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03434613 Completed Yonsei University 2019-09-11
NCT01267227 Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress https://ClinicalTrials.gov/show/NCT01267227 Completed University of Mississippi Medical Center 2012-02-29
NCT01256476 Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT01256476 Completed Kowa Research Institute, Inc. 2011-06-30
NCT01236430 A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551) https://ClinicalTrials.gov/show/NCT01236430 Completed Merck Sharp & Dohme Corp. 2011-11-30
NCT01212159 Telephone Based Management of Hyperlipidemia https://ClinicalTrials.gov/show/NCT01212159 Completed Temple University 2015-07-31
NCT01152073 A Study Of Nutraceutical Drinks For Cholesterol (Evaluating Effectiveness and Tolerability) https://ClinicalTrials.gov/show/NCT01152073 Completed Healthy Drink Discoveries, Inc. 2010-09-30
NCT01146522 Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia https://ClinicalTrials.gov/show/NCT01146522 Completed Novartis 2011-10-31
NCT01142908 Cardiovascular Intervention Improvement Telemedicine Study https://ClinicalTrials.gov/show/NCT01142908 Completed VA Office of Research and Development 2015-04-30
NCT01133522 Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Evolocumab (AMG 145) in Adults With Hyperlipidemia on Stable Doses of a Statin https://ClinicalTrials.gov/show/NCT01133522 Completed Amgen 2011-09-14
NCT01099176 Effects of Hypolipemic Treatment on Adipokines https://ClinicalTrials.gov/show/NCT01099176 Completed Medical University of Silesia 2009-05-31
NCT01089231 Effects of Omega-3 Fatty Acids on the Human Gene Expression https://ClinicalTrials.gov/show/NCT01089231 Completed Gottfried Wilhelm Leibniz Universität Hannover 2010-07-31
NCT01057654 A Study Comparing the Mechanisms of Action of Lifibrol and Pravastatin https://ClinicalTrials.gov/show/NCT01057654 Completed University Hospital, Bonn 1996-04-30
NCT01023607 Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS) https://ClinicalTrials.gov/show/NCT01023607 Completed Harbin Medical University 2013-08-31
NCT00974272 Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation https://ClinicalTrials.gov/show/NCT00974272 Completed Carl T. Hayden VA Medical Center 2008-11-30
NCT00973115 Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT00973115 Completed Hanmi Pharmaceutical Company Limited 2009-08-31
NCT00941603 Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675) https://ClinicalTrials.gov/show/NCT00941603 Completed Merck Sharp & Dohme Corp. 2010-02-22
NCT00917878 Postprandial Effects of Milk and Milk Constituents https://ClinicalTrials.gov/show/NCT00917878 Completed Maastricht University Medical Center 2009-07-31
NCT00897975 Red Yeast Rice and Phytosterols In Statin Intolerance https://ClinicalTrials.gov/show/NCT00897975 Completed Chestnut Hill Health System 2010-11-30
NCT00887653 Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy https://ClinicalTrials.gov/show/NCT00887653 Completed The Miriam Hospital 2012-06-30
NCT02833844 Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT02833844 Completed Amgen 2019-07-09
NCT00813527 Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels https://ClinicalTrials.gov/show/NCT00813527 Completed Takeda 2007-01-31
NCT00810979 Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT00810979 Completed Kadmon Corporation, LLC 2009-09-30
NCT01645046 The Effects of Coenzyme A on Serum Lipids in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT01645046 Completed Zhejiang University 2009-06-30
NCT02100839 Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia https://ClinicalTrials.gov/show/NCT02100839 Completed LipimetiX Development, LLC 2014-11-30
NCT03961763 Effect of n-3 Fatty Acid Supplementation in Hyperlipidemic Patients Taking Statins https://ClinicalTrials.gov/show/NCT03961763 Completed University of Chester 2017-11-01
NCT03828188 Efficacy and Safety of Red Ginseng Concentrated Powder on Improvement of Blood Triglyceride Level https://ClinicalTrials.gov/show/NCT03828188 Completed Chonbuk National University Hospital 2018-05-11
NCT00947635 Cholesterol and Fatty Acid Synthesis in Islet and Liver Transplant Patients and Effect of Dietary Intervention https://ClinicalTrials.gov/show/NCT00947635 Completed University of Alberta 2009-06-30
NCT00754039 Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol https://ClinicalTrials.gov/show/NCT00754039 Completed Daiichi Sankyo, Inc. 2003-09-30
NCT00713167 The Efficacy of Red Grape Seed Extract on Lipid Profile and Oxidized Low-Density Lipoprotein (OX-LDL) https://ClinicalTrials.gov/show/NCT00713167 Completed Shahid Beheshti University of Medical Sciences 2008-12-31
NCT00701883 Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol https://ClinicalTrials.gov/show/NCT00701883 Completed CymaBay Therapeutics, Inc. 2008-08-31
NCT00694109 An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia https://ClinicalTrials.gov/show/NCT00694109 Completed Kastle Therapeutics, LLC 2014-09-30
NCT00688896 Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia https://ClinicalTrials.gov/show/NCT00688896 Completed Akros Pharma Inc. 2003-04-30
NCT00686010 Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia https://ClinicalTrials.gov/show/NCT00686010 Completed Japan Tobacco Inc. 2001-01-31
NCT00685737 Safety of a Hypolipidemic Agent in Healthy Normal Volunteers https://ClinicalTrials.gov/show/NCT00685737 Completed Pharmena North America 2008-06-30
NCT00668109 Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia https://ClinicalTrials.gov/show/NCT00668109 Completed Bayer 2004-06-30
NCT00645424 A Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High Cholesterol https://ClinicalTrials.gov/show/NCT00645424 Completed Pfizer NA
NCT00607373 Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia https://ClinicalTrials.gov/show/NCT00607373 Completed Kastle Therapeutics, LLC 2009-03-31
NCT01239004 Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy https://ClinicalTrials.gov/show/NCT01239004 Completed Radiant Research 2011-08-31
NCT00565292 A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED) https://ClinicalTrials.gov/show/NCT00565292 Completed Merck Sharp & Dohme Corp. 2006-08-31
NCT00552097 Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578) https://ClinicalTrials.gov/show/NCT00552097 Completed Merck Sharp & Dohme Corp. 2006-04-25
NCT00536510 Effect of MK0524A on Cholesterol Levels (0524A-048) https://ClinicalTrials.gov/show/NCT00536510 Completed Merck Sharp & Dohme Corp. 2008-03-31
NCT00507520 Almond Dose Response Study. https://ClinicalTrials.gov/show/NCT00507520 Completed University of Toronto NA
NCT00490672 Community Based Multiple Risk Factors Intervention Strategy https://ClinicalTrials.gov/show/NCT00490672 Completed Ministry of Health, Malaysia 2008-12-31
NCT00477594 Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia https://ClinicalTrials.gov/show/NCT00477594 Completed Kastle Therapeutics, LLC 2011-03-31
NCT00473655 Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients https://ClinicalTrials.gov/show/NCT00473655 Completed AstraZeneca 2009-02-28
NCT00465088 An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) https://ClinicalTrials.gov/show/NCT00465088 Completed Abbott 2008-02-29
NCT00459745 A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia https://ClinicalTrials.gov/show/NCT00459745 Completed Shionogi Inc. 2008-04-30
NCT00457262 Effects of Soy Protein on Serum paraoxonase1 Activity and Lipoproteins in Postmenopausal Women https://ClinicalTrials.gov/show/NCT00457262 Completed Iran University of Medical Sciences NA
NCT00438425 Portfolio 5 - Multicentre Dietary Advice on Serum Lipids in Hyperlipidemia https://ClinicalTrials.gov/show/NCT00438425 Completed University of Toronto 2009-09-30
NCT00405769 Lipid Lowering in Patients With Statin Intolerance https://ClinicalTrials.gov/show/NCT00405769 Completed Chestnut Hill Health System NA
NCT00393419 Federal Study of Adherence to Medications in the Elderly (FAME) https://ClinicalTrials.gov/show/NCT00393419 Completed Walter Reed Army Medical Center NA
NCT00378833 Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054) https://ClinicalTrials.gov/show/NCT00378833 Completed Merck Sharp & Dohme Corp. 2007-03-31
NCT00376584 Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED) https://ClinicalTrials.gov/show/NCT00376584 Completed Merck Sharp & Dohme Corp. 2007-01-31
NCT00362934 Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin https://ClinicalTrials.gov/show/NCT00362934 Completed Solvay Pharmaceuticals 2008-08-31
NCT00362206 Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin https://ClinicalTrials.gov/show/NCT00362206 Completed Solvay Pharmaceuticals 2008-09-30
NCT00362180 Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration https://ClinicalTrials.gov/show/NCT00362180 Completed Kastle Therapeutics, LLC 2010-03-31
NCT00360217 The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes https://ClinicalTrials.gov/show/NCT00360217 Completed Maine Center for Lipids and Cardiovascular Health NA
NCT00349375 Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy https://ClinicalTrials.gov/show/NCT00349375 Completed Solvay Pharmaceuticals 2008-09-30
NCT00349284 A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome https://ClinicalTrials.gov/show/NCT00349284 Completed Solvay Pharmaceuticals NA
NCT00345657 Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care https://ClinicalTrials.gov/show/NCT00345657 Completed In His Image NA
NCT00308386 DYNAMIC Study: (Diabetes Nurse Case Management And Motivational Interviewing for Change) https://ClinicalTrials.gov/show/NCT00308386 Completed Milton S. Hershey Medical Center 2011-07-27
NCT00296400 Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease https://ClinicalTrials.gov/show/NCT00296400 Completed AstraZeneca 2009-06-30
NCT00289900 Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) https://ClinicalTrials.gov/show/NCT00289900 Completed Merck Sharp & Dohme Corp. 2010-08-06
NCT00271817 To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED) https://ClinicalTrials.gov/show/NCT00271817 Completed Merck Sharp & Dohme Corp. 2008-02-29
NCT00269217 Lipid Efficacy Study (0524B-022)(COMPLETED) https://ClinicalTrials.gov/show/NCT00269217 Completed Merck Sharp & Dohme Corp. 2007-01-31
NCT00269204 Lipid Efficacy/Tolerability Study (0524A-020) https://ClinicalTrials.gov/show/NCT00269204 Completed Merck Sharp & Dohme Corp. 2006-12-31
NCT00249938 Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol. https://ClinicalTrials.gov/show/NCT00249938 Completed University of Colorado, Denver NA
NCT00246402 Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV https://ClinicalTrials.gov/show/NCT00246402 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00244231 Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia https://ClinicalTrials.gov/show/NCT00244231 Completed Genovate Biotechnology Co., Ltd., NA
NCT00227500 Pravastatin for Hyperlipidaemia in HIV. https://ClinicalTrials.gov/show/NCT00227500 Completed Kirby Institute NA
NCT00214604 Type III Dysbetalipoproteinemia https://ClinicalTrials.gov/show/NCT00214604 Completed AstraZeneca 2007-02-28
NCT00211705 Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study) https://ClinicalTrials.gov/show/NCT00211705 Completed Mitsukoshi Health and Welfare Foundation NA
NCT00203476 A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction https://ClinicalTrials.gov/show/NCT00203476 Completed Tuscaloosa Research & Education Advancement Corporation 2008-01-31
NCT00195793 A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin https://ClinicalTrials.gov/show/NCT00195793 Completed Abbott NA
NCT00189085 Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function https://ClinicalTrials.gov/show/NCT00189085 Completed UMC Utrecht NA
NCT00184951 Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients https://ClinicalTrials.gov/show/NCT00184951 Completed Radboud University 2005-07-31
NCT00174330 Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia https://ClinicalTrials.gov/show/NCT00174330 Completed Pfizer NA
NCT00160329 Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT00160329 Completed Stanford University 2007-04-30
NCT00139061 Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate https://ClinicalTrials.gov/show/NCT00139061 Completed Pfizer NA
NCT00134498 A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides https://ClinicalTrials.gov/show/NCT00134498 Completed Pfizer NA
NCT00117494 Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126) https://ClinicalTrials.gov/show/NCT00117494 Completed French National Agency for Research on AIDS and Viral Hepatitis 2007-03-31
NCT00114855 The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose https://ClinicalTrials.gov/show/NCT00114855 Completed Oslo University Hospital 2005-12-31
NCT00093899 A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED) https://ClinicalTrials.gov/show/NCT00093899 Completed Merck Sharp & Dohme Corp. 2005-09-30
NCT00092573 Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED) https://ClinicalTrials.gov/show/NCT00092573 Completed Merck Sharp & Dohme Corp. 2004-11-30
NCT00092560 Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036) https://ClinicalTrials.gov/show/NCT00092560 Completed Merck Sharp & Dohme Corp. 2003-12-31
NCT00552747 Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease https://ClinicalTrials.gov/show/NCT00552747 Completed National Heart Institute, Mexico 2010-03-31
NCT00108459 Low Carbohydrate Diet Compared to Calorie and Fat Restricted Diet in Patients With Obesity and Type II Diabetes https://ClinicalTrials.gov/show/NCT00108459 Completed VA Office of Research and Development NA
NCT00006493 Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia https://ClinicalTrials.gov/show/NCT00006493 Completed National Center for Research Resources (NCRR) NA
NCT00000538 Dietary Effects on Lipoproteins and Thrombogenic Activity (DELTA) https://ClinicalTrials.gov/show/NCT00000538 Completed University of North Carolina, Chapel Hill 1995-05-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT02933138 Plasma Triglyceride Lipolysis in Multifactorial Chylomicronemia https://ClinicalTrials.gov/show/NCT02933138 Completed Hospices Civils de Lyon 2012-07-31
NCT02826720 Is There a Relationship Between Hyperlipidemia and Periodontitis? https://ClinicalTrials.gov/show/NCT02826720 Completed Marmara University 2016-01-31
NCT02808130 PERIODONTAL DISEASE AND HYPERLIPIDEMIA https://ClinicalTrials.gov/show/NCT02808130 Completed Ondokuz Mayıs University 2014-08-31
NCT02791802 Effect of Lipoprotein(a) Elimination by Lipoprotein Apheresis on Cardiovascular Outcomes https://ClinicalTrials.gov/show/NCT02791802 Recruiting Technische Universität Dresden 2020-06-30
NCT02770131 Chart Review of Repatha® in Subjects With Hyperlipidaemia https://ClinicalTrials.gov/show/NCT02770131 Recruiting Amgen 2021-06-24
NCT02730390 Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing Surveillance https://ClinicalTrials.gov/show/NCT02730390 Completed Otsuka Pharmaceutical, Inc., Philippines 2013-07-31
NCT01753232 Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter https://ClinicalTrials.gov/show/NCT01753232 Completed Fresenius Medical Care Deutschland GmbH 2014-12-31
NCT01592084 Hyperlipidemia and Statin Therapy in Amyotrophic Lateral Sclerosis https://ClinicalTrials.gov/show/NCT01592084 Completed The Methodist Hospital System 2011-09-30
NCT01393249 PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALL https://ClinicalTrials.gov/show/NCT01393249 Completed Rigshospitalet, Denmark 2013-12-31
NCT04330209 Comparing a Low-GI Nutrigenetic and Ketogenic Diet for Weight Loss With 18 Month Follow-up https://ClinicalTrials.gov/show/NCT04330209 Completed Iuliu Hatieganu University of Medicine and Pharmacy 2016-12-31
NCT00891124 Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol). https://ClinicalTrials.gov/show/NCT00891124 Completed AstraZeneca NA
NCT00882336 European Study of Cardiovascular Risk https://ClinicalTrials.gov/show/NCT00882336 Completed AstraZeneca NA
NCT00828945 Compliance With Treatment For Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT00828945 Completed Pfizer 2011-03-31
NCT03329729 PLATOREL® STUDY IN CARDIOVASCULAR RISΚ ASSESMENT https://ClinicalTrials.gov/show/NCT03329729 Completed Elpen Pharmaceutical Co. Inc. 2019-01-30
NCT00781560 Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal https://ClinicalTrials.gov/show/NCT00781560 Completed AstraZeneca NA
NCT00726362 To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT00726362 Completed AstraZeneca 2009-11-30
NCT00701454 Survey of Thai-Muslim Health Status https://ClinicalTrials.gov/show/NCT00701454 Completed Mahidol University 2006-04-30
NCT00536965 Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets https://ClinicalTrials.gov/show/NCT00536965 Completed AstraZeneca 2007-12-31
NCT00536796 Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets https://ClinicalTrials.gov/show/NCT00536796 Completed AstraZeneca 2007-12-31
NCT00534105 Lipid Metabolism in Gestational Diabetes https://ClinicalTrials.gov/show/NCT00534105 Completed Baystate Medical Center 2010-11-30
NCT00516204 Diabetic Under 70 (Diabetics Below 70) https://ClinicalTrials.gov/show/NCT00516204 Completed AstraZeneca 2007-12-31
NCT00451464 Studies of Apolipoprotein Genotyping on the Drug Treatment of Hyperlipidemic Patients https://ClinicalTrials.gov/show/NCT00451464 Completed National Taiwan University Hospital NA
NCT00381992 Risk Assessment of Long-Haul Truck Drivers https://ClinicalTrials.gov/show/NCT00381992 Completed Wake Forest University Health Sciences 2010-03-31
NCT00365235 Understanding the Genetic Basis of Familial Combined Hyperlipidemia in Mexican Individuals https://ClinicalTrials.gov/show/NCT00365235 Completed University of California, Los Angeles 2011-06-30
NCT00001142 Metabolism and Body Shape of Healthy Children and Children With Chronic Infections https://ClinicalTrials.gov/show/NCT00001142 Completed National Institutes of Health Clinical Center (CC) NA
NCT00005368 Genetic Epidemiology of Hypertriglyceridemia https://ClinicalTrials.gov/show/NCT00005368 Completed University of Washington NA
NCT00005313 Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia https://ClinicalTrials.gov/show/NCT00005313 Completed University of Washington 2003-03-31
NCT00005128 Lipid Research Clinics Population Studies https://ClinicalTrials.gov/show/NCT00005128 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00001226 Lipoprotein Metabolism in Normal Volunteers and Patients With Abnormal Levels of Lipoproteins https://ClinicalTrials.gov/show/NCT00001226 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03293810 Glybera Registry, Lipoprotein Lipase Deficient (LPLD) Patients https://ClinicalTrials.gov/show/NCT03293810 Active, not recruiting UniQure Biopharma B.V. 2033-09-30
NCT03065543 Hyperlipidemia Therapy TERCET Zabrze Registry https://ClinicalTrials.gov/show/NCT03065543 Recruiting Silesian Centre for Heart Diseases 2016-12-31